China SXT Pharmaceuticals, Inc. (SXTC): Price and Financial Metrics
GET POWR RATINGS... FREE!
SXTC POWR Grades
- SXTC scores best on the Value dimension, with a Value rank ahead of 81.44% of US stocks.
- SXTC's strongest trending metric is Value; it's been moving up over the last 35 days.
- SXTC ranks lowest in Stability; there it ranks in the 2nd percentile.
SXTC Stock Summary
- SXTC has a market capitalization of $1,029,672 -- more than approximately just 0.07% of US stocks.
- With a year-over-year growth in debt of 1,878.2%, CHINA SXT PHARMACEUTICALS INC's debt growth rate surpasses 98.77% of about US stocks.
- Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for SXTC comes in at -526.48% -- higher than that of only 1.41% of stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to CHINA SXT PHARMACEUTICALS INC are CLEU, BTB, TWKS, AREB, and SOPA.
- Visit SXTC's SEC page to see the company's official filings. To visit the company's web site, go to www.sxtchina.com.
SXTC Valuation Summary
- In comparison to the median Healthcare stock, SXTC's price/earnings ratio is 100.88% lower, now standing at -0.2.
- SXTC's EV/EBIT ratio has moved down 79 over the prior 51 months.
Below are key valuation metrics over time for SXTC.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| SXTC | 2023-03-17 | 2.9 | 0.1 | -0.2 | 0.2 |
| SXTC | 2023-03-16 | 3.2 | 0.1 | -0.3 | 0.2 |
| SXTC | 2023-03-15 | 3.2 | 0.1 | -0.3 | 0.2 |
| SXTC | 2023-03-14 | 2.9 | 0.1 | -0.2 | 0.2 |
| SXTC | 2023-03-13 | 3.2 | 0.1 | -0.3 | 0.2 |
| SXTC | 2023-03-10 | 3.2 | 0.1 | -0.3 | 0.2 |
SXTC Stock Price Chart Interactive Chart >
SXTC Price/Volume Stats
| Current price | $0.33 | 52-week high | $9.98 |
| Prev. close | $0.29 | 52-week low | $0.27 |
| Day low | $0.28 | Volume | 655,900 |
| Day high | $0.36 | Avg. volume | 451,221 |
| 50-day MA | $0.47 | Dividend yield | N/A |
| 200-day MA | $0.97 | Market Cap | 670.03K |
China SXT Pharmaceuticals, Inc. (SXTC) Company Bio
China Sxt Pharmaceuticals, Inc. engages in the development, manufacture, marketing, sales, research and development of Chinese traditional medicine. It sells Advanced TCMP, Fine TCMP and Regular TCMP products. The company sell its products under "Suxuantang" brand name. The company was founded by Zhou Feng in 2005 and is headquartered in Taizhou, China.
Latest SXTC News From Around the Web
Below are the latest news stories about CHINA SXT PHARMACEUTICALS INC that investors may wish to consider to help them evaluate SXTC as an investment opportunity.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayWe're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about for Tuesday morning! |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayThe trading week is almost complete but we've still got the biggest pre-market stock movers to go over for Friday morning! |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayThe biggest pre-market stock movers for Monday include many Chinese shares that traders will want to keep an eye on today! |
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price DeficiencyJiangsu, China, Nov. 07, 2022 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (“SXTC” or the “Company”), (NASDAQ: SXTC) announced today that on November 3, 2022, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC (“Nasdaq”) notifying the Company that the minimum bid price per share for its ordinary shares has been below $1.00 for a period of 30 consecutive business days and the Company therefore no longer meets the minimum b |
China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share SplitTAIZHOU, China, May 18, 2022 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements ("TCMHS") announced today that an 1 for 20 reverse split of its ordinary shares |
SXTC Price Returns
| 1-mo | -25.00% |
| 3-mo | -41.05% |
| 6-mo | -62.92% |
| 1-year | -91.86% |
| 3-year | -99.29% |
| 5-year | N/A |
| YTD | -39.11% |
| 2022 | -95.83% |
| 2021 | -50.54% |
| 2020 | -59.91% |
| 2019 | N/A |
| 2018 | N/A |
Continue Researching SXTC
Here are a few links from around the web to help you further your research on China SXT Pharmaceuticals Inc's stock as an investment opportunity:China SXT Pharmaceuticals Inc (SXTC) Stock Price | Nasdaq
China SXT Pharmaceuticals Inc (SXTC) Stock Quote, History and News - Yahoo Finance
China SXT Pharmaceuticals Inc (SXTC) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...